Income statement, balance sheet and cash flow statement for the last 2 fiscal years, taken from the XBRL data BUDA JUICE, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2025
FY2025
Revenue
11.3
12.6
Cost of revenue
6.07
6.98
Gross profit
5.21
5.63
Selling, general and administrative
1.3
1.67
Operating expenses
1.8
2.18
Operating income
3.41
3.45
Income tax
0
Net income
3.57
3.53
EBITDA
3.69
3.69
EPS, basic
0.28
0.28
EPS, diluted
0.20
0.20
Shares, basic (weighted)
0.01
0.01
Shares, diluted (weighted)
0.01
0.01
Balance sheet
FY2025
FY2025
Cash and equivalents
1.89
1.84
Receivables
0.4
0.39
Inventory
0.37
0.35
Other current assets
0.04
0.65
Total current assets
2.7
3.22
Property, plant and equipment
0.97
0.98
Lease right-of-use assets
0.07
0.78
Total assets
3.73
4.97
Accounts payable
0.45
0.29
Total current liabilities
0.58
0.59
Long-term debt
0.65
Lease liabilities
0.65
Total liabilities
0.58
1.23
Total debt
0.65
Retained earnings
-2.35
1.18
Shareholders' equity
3.16
3.74
Total equity
3.16
3.74
Total liabilities and equity
3.73
4.97
Shares outstanding
12.6
Cash flow statement
FY2025
FY2025
Net income
3.57
3.53
Depreciation and amortization
0.27
0.24
Change in receivables
-0.03
0.01
Change in inventory
0.03
0.03
Change in payables
0.17
-0.05
Cash from operations
3.97
3.15
Capital expenditures
-0.68
-0.25
Cash from investing
-0.68
-0.25
Cash from financing
-2.83
-2.95
Net change in cash
0.46
-0.05
Free cash flow
3.29
2.9
Interest paid
0.09
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $7.15 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
44.6%
Gross profit / revenue.
Operating margin
27.4%
Operating income / revenue.
EBITDA margin
29.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
28.0%
Net income / revenue.
FCF margin
23.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
25.0%
Cash from operations / revenue.
Return on equity (ROE)
102.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
81.2%
Net income / average total assets.
Return on invested capital (ROIC)
142.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
13.3%
Selling, general and administrative expense / revenue.
Capex / revenue
2.0%
Capital expenditures / revenue.
D&A / revenue
1.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
11.8%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
8.1%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
1.1%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
0.1%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-1.1%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
0.0%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-20.7%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-11.7%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
18.4%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
33.2%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
5.50x
Current assets / current liabilities.
Quick ratio
3.81x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
3.15x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.17x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
13.0%
Total debt / total assets.
Liabilities / assets
24.8%
Total liabilities / total assets.
Net debt
-$1.2M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
-0.32x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Days inventory + days sales outstanding - days payables.
FCF conversion
82.2%
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
7.8%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.20
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$0.28
Net income per basic share, as reported (split-adjusted).
Revenue per share
$900.64
Revenue / diluted weighted shares.
FCF per share
$207.43
Free cash flow / diluted weighted shares.
Operating cash flow per share
$225.00
Cash from operations / diluted weighted shares.
Book value per share
$0.30
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
25.4x
Market cap / net income. Only when net income is positive.
P/S
7.13x
Market cap / revenue.
P/B
24.0x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
24.0x
Market cap / tangible book value, when positive.
P/FCF
30.9x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
28.5x
Market cap / cash from operations, when positive.
EV/Sales
7.03x
Enterprise value / revenue.
EV/EBIT
25.7x
Enterprise value / operating income, when both are positive.
EV/EBITDA
24.0x
Enterprise value / EBITDA, when both are positive.
EV/FCF
30.5x
Enterprise value / free cash flow, when both are positive.
FCF yield
3.2%
Free cash flow / market cap.
Earnings yield
3.9%
Net income / market cap (the inverse of P/E).
What was BUDA JUICE, INC.'s revenue in fiscal 2025?
BUDA JUICE, INC. reported revenue of $12.6M for fiscal 2025, 11.8% higher than the year before.
Was BUDA JUICE, INC. profitable in fiscal 2025?
Yes. Net income was $3.5M, a net margin of 28%.
How much free cash flow did BUDA JUICE, INC. generate in fiscal 2025?
Cash from operations of $3.2M minus capital expenditures of $246.0K left free cash flow of $2.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.